Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $5.49 million. The enterprise value is -$1.77 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 3.64 million shares outstanding. The number of shares has increased by 614.35% in one year.
| Current Share Class | 3.64M |
| Shares Outstanding | 3.64M |
| Shares Change (YoY) | +614.35% |
| Shares Change (QoQ) | +25.67% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 10.91% |
| Float | 3.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.25 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.17% and return on invested capital (ROIC) is -14.67%.
| Return on Equity (ROE) | -21.17% |
| Return on Assets (ROA) | -11.78% |
| Return on Invested Capital (ROIC) | -14.67% |
| Return on Capital Employed (ROCE) | -24.58% |
| Revenue Per Employee | $696,819 |
| Profits Per Employee | -$96,732 |
| Employee Count | 52 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 2.58 |
Taxes
| Income Tax | -297,372 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.27% in the last 52 weeks. The beta is 0.96, so SBFM's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -85.27% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 54.21 |
| Average Volume (20 Days) | 104,802 |
Short Selling Information
The latest short interest is 258,996, so 7.12% of the outstanding shares have been sold short.
| Short Interest | 258,996 |
| Short Previous Month | 395,540 |
| Short % of Shares Out | 7.12% |
| Short % of Float | 7.76% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
In the last 12 months, SBFM had revenue of $36.23 million and -$5.03 million in losses. Loss per share was -$4.14.
| Revenue | 36.23M |
| Gross Profit | 11.05M |
| Operating Income | -5.76M |
| Pretax Income | -3.72M |
| Net Income | -5.03M |
| EBITDA | -5.51M |
| EBIT | -5.76M |
| Loss Per Share | -$4.14 |
Full Income StatementBalance Sheet
The company has $8.20 million in cash and $936,182 in debt, giving a net cash position of $7.26 million or $2.00 per share.
| Cash & Cash Equivalents | 8.20M |
| Total Debt | 936,182 |
| Net Cash | 7.26M |
| Net Cash Per Share | $2.00 |
| Equity (Book Value) | 22.70M |
| Book Value Per Share | 8.38 |
| Working Capital | 18.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.06 million and capital expenditures -$1.60 million, giving a free cash flow of -$12.66 million.
| Operating Cash Flow | -11.06M |
| Capital Expenditures | -1.60M |
| Free Cash Flow | -12.66M |
| FCF Per Share | -$3.48 |
Full Cash Flow StatementMargins
Gross margin is 30.48%, with operating and profit margins of -15.89% and -13.88%.
| Gross Margin | 30.48% |
| Operating Margin | -15.89% |
| Pretax Margin | -14.70% |
| Profit Margin | -13.88% |
| EBITDA Margin | -15.21% |
| EBIT Margin | -15.89% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -614.35% |
| Shareholder Yield | -614.35% |
| Earnings Yield | -91.62% |
| FCF Yield | -230.62% |
Analyst Forecast
The average price target for SBFM is $15.00, which is 893.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 893.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2024. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Aug 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |